[Corrigendum] (‑)‑Epigallocatechin‑3‑gallate attenuates myocardial injury induced by ischemia/reperfusion in diabetic rats and in H9c2 cells under hyperglycemic conditions. [PDF]
Wu Y +8 more
europepmc +1 more source
Effect of Epigallocatechin-3-Gallate on Depression-Related Cytokines in Thalassemia Patients: Molecular and Cellular Evaluation. [PDF]
Salman MN +5 more
europepmc +1 more source
Effect of Melatonin and Epigallocatechin-3-Gallate Combination on In Vitro Maturation of Mouse Oocytes. [PDF]
Li S, Chen L, Li Y, Xu L, Chen Y, Ma Y.
europepmc +1 more source
Epigallocatechin-3-Gallate Suppresses Glioma by Targeting Integrin αvβ3/FAK/ERK Signaling Axis and Matrix Metalloproteinases. [PDF]
Sun R +7 more
europepmc +1 more source
Engineering Resatorvid-Loaded Sub-Microgels of Epigallocatechin-3-gallate/Hyaluronic Acid to Treat Acute Lung Injury. [PDF]
Liu B +10 more
europepmc +1 more source
Inhibitory effect of epigallocatechin-3-gallate as a potent anti-amyloidogenic agent against the G138E mutant of SOD1. [PDF]
Sheikhpour Z +5 more
europepmc +1 more source
Enhanced anti-tumor activity by the combination of the natural compounds (-)-epigallocatechin-3-gallate and luteolin. [PDF]
Amin ARMR +9 more
europepmc +1 more source
Desensitization of the Cardiac Troponin Complex by TnI Phosphorylation and Epigallocatechin-3-Gallate. [PDF]
Tigro H +5 more
europepmc +1 more source
Effects of (-)-Epigallocatechin-3-gallate non-covalent binding on the functional and structural properties of pumpkin seed protein isolate. [PDF]
Liu P +8 more
europepmc +1 more source
Efficacy and safety of 7-day aerosolized epigallocatechin-3-gallate in oncologic patients with COVID-19 pneumonia. [PDF]
Zhu W +7 more
europepmc +1 more source

